Analystreport

Biogen (NASDAQ:BIIB) had its "sell (d+)" rating reaffirmed by analysts at Weiss Ratings.

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html